These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7004750)

  • 1. [A new non-steroid anti-inflammatory agent in therapy of osteoarthrosis].
    Loizzi P
    Clin Ter; 1980 Mar; 92(5):497-512. PubMed ID: 7004750
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of bufexamac for rheumatoid arthritis.
    Rose BS; Isdale IC; Conlon PW
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):150-3. PubMed ID: 4985493
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of tolerability and clinical efficacy of acetylsalicylic acid and a new nonsteroid anti-inflammatory drug in osteoarthritis].
    Debolini A; Marcolongo R; Granelli G
    Clin Ter; 1977 Sep; 82(6):531-49. PubMed ID: 338238
    [No Abstract]   [Full Text] [Related]  

  • 4. A non-steroidal anti-inflammatory cream. A report from the General Practitioner Research Group.
    Practitioner; 1975 May; 214(1283):689-692. PubMed ID: 1096128
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental and clinical study of a new non-steroidal anti-inflammatory agent: butoxyphenylacetylhydroxamic acid (Droxaryl)].
    Van Cauwenberge H
    Rev Rhum Mal Osteoartic; 1967 Sep; 34(9):480-8. PubMed ID: 4384373
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin.
    Pavelka K; Wagenhauser F
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):69-72. PubMed ID: 4984321
    [No Abstract]   [Full Text] [Related]  

  • 7. Arthritis: anti-inflammatory drugs in practice.
    Dieppe P; Doyle D; Jacoby R
    Practitioner; 1981 Mar; 225(1353):397-9. PubMed ID: 7022432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical study of a new non-steroid anti-inflammatory agent: butoxyphenylacethydroxamic acid (Droxaryl)].
    Van Cauwenberge H; Franchimont P
    J Belge Rhumatol Med Phys; 1968; 23(3):133-48. PubMed ID: 5758165
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimentation and clinical evaluation of ibuprofen, a new synthetic non-steroid antirheumatic agent].
    Perpignano G
    Minerva Med; 1973 Jun; 64(47):2471-4. PubMed ID: 4579838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].
    Aertgeerts P; Albring M; Klaschka F; Nasemann T; Patzelt-Wenczler R; Rauhut K; Weigl B
    Z Hautkr; 1985 Feb; 60(3):270-7. PubMed ID: 3158124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Namoxyrate in rheumatic disorders.
    Denko CW; DeFelice EA; Shaffer J
    Curr Ther Res Clin Exp; 1965 Dec; 7(12):749-58. PubMed ID: 4954445
    [No Abstract]   [Full Text] [Related]  

  • 12. Meclofenamate sodium (meclomen) a new antiarthritic agent.
    Med Lett Drugs Ther; 1980 Dec; 22(26):111-2. PubMed ID: 7005638
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bufexamac in the treatment of progressive polyarthritis. Double-blind test using phenylbutazone, too].
    Pavelka K; Vojtísek O; Brémová A; Hándlová D; Kanková D; Králová M
    Cas Lek Cesk; 1972; 111(22):514-7. PubMed ID: 5031749
    [No Abstract]   [Full Text] [Related]  

  • 14. Intra-articular treatment of inflammatory arthritis: double-blind trial comparing bufexamac with methylprednisolone acetate.
    Mielants H; Raeman F; Proot F; Veys EM
    Clin Rheumatol; 1987 Mar; 6(1):55-60. PubMed ID: 3555968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experiences with a new non-steroid antirheumatic agent].
    Carcassi A
    Minerva Med; 1973; 64(45):2361-4. PubMed ID: 4733891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inflamed dermatoses. Treatment with Bufexamac. A randomized comparative double-blind study against fluocortinbutyl ester].
    Vakilzadeh F; Macher E
    ZFA (Stuttgart); 1983 Nov; 59(33):1888-91. PubMed ID: 6362257
    [No Abstract]   [Full Text] [Related]  

  • 17. General dermatologic use of hydroxamic acid.
    Solano E
    Clin Ther; 1980; 3(4):229-33. PubMed ID: 7273060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of rheumatic disorders in general practice. A comparative study of aspirin and an alkali-phenylbutazone preparation.
    Lewis-Faning E; Fowler PD
    Br J Clin Pract; 1971 Mar; 25(3):123-9. PubMed ID: 4929158
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between structure and four types of pharmacologic activity in arylacetydroxamic acids.
    Lambelin G; Buu-Hoï NP; Brouilhet H; Gautier M; Gillet C; Roba J; Thiriaux J
    Arzneimittelforschung; 1968 Nov; 18(11):1404-8. PubMed ID: 4885157
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of bufexamac suppositories in rectal conditions.
    Samsi AB
    J Postgrad Med; 1975 Jul; 21(3):131-4. PubMed ID: 1206602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.